Industry News

Minerva Neurosciences Announces Completion of FDA Review of Investigational New Drug Application for MIN-202 and Plans for First U.S.-Based Clinical Trial Bioavailability Study in U.S. for Investigational Therapy in Development for Treatment of Insomnia t
FDA Approves Stendra sNDA
FDA warns doctors to beware fake drug distributors
Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE VIABAHN Endoprosthesis
NovaDel Announces the Sale of Its ZolpiMist New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC
Foster Delivery Science To Build Facility For Manufacturing Drug Delivery Polymers
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
NovaDel Announces the Sale of Its ZolpiMist� New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC
Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE� VIABAHN� Endoprosthesis
Auxilium Pharma rejects Endo's takeover offer
Merck Gets FDA Approval of Keytruda
Taxes and subsidies could encourage healthier diet and lower healthcare costs Tufts University, Health Sciences Campus
Lundbeck Introduces NORTHERA (droxidopa) Capsules in the U.S. for Symptomatic Neurogenic Orthostatic Hypotension
ACADIA Pharmaceuticals Secures FDA Breakthrough Therapy Designation for NUPLAZID for Parkinson's Disease Psychosis
Ipsen Secures FDA Priority Review for Somatuline in Treatment of GEP- NETs in U.S.
FDA Approves the Use of a Needle-Free Injection Device to Administer the Influenza Vaccine
Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax Vaccine
Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax� Vaccine
PCI Announces Acquisition Of Biotec PCI significantly expands Global Clinical Services business through Biotec acquisition
FDA OKs faster-acting label for ED drug Stendra
Minerva Neurosciences Announces Completion of FDA Review of Investigational New Drug Application for MIN-202 and Plans for First U.S.-Based Clinical Trial Bioavailability Study in U.S. for Investigational Therapy in Development for Treatment of Insomnia t
Baxter Gets FDA Approval for RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with Hemophilia B
U.S. House of Representatives Passes Paulsen Legislation to Repeal Medical Device Tax
FDA Warns Against Non-approved Dermal Filler
AlloSource Signs Space Act Agreement With NASA And Jet Propulsion Laboratory Technology used in NASA Mars missions will provide insights into microbial testing related to tissue processing